Hepatitis A Virus, ABS-IgG (HAV IgG)
Code
2855
Principle
The presence of IgG anti-HAV, with a nonreactive IgM anti-HAV test result, implies past infection with hepatitis A virus (HAV) or vaccination against HAV.
Preanalytical
1 mL Serum Refrigerated
Turn Around Time
1 day
Methodology
Chemiluminescent microparticle immunoassay (CMIA)
Limitations
Specimens from patients who have received preparations of mouse monoclonal antibodies for diagnosis or therapy may contain human anti-mouse antibodies (HAMA). Specimens containing HAMA may produce anomalous values when tested.